NEBL and cancer: In line, knockdown of LASP2 enhanced the malignant phenotype of human liver (Li et al, 2020) and colorectal cancer (Wang et al, 2017) cells, whereas overexpression was found to inhibit proliferation and migration in human colorectal (Wang et al, 2017), bladder (Yang et al, 2018), pancreatic (Zhang et al, 2019), and liver (Li et al, 2020) cancer cell lines.